The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 49 | — | 20.1x | Near average | |
Growth | 50 | 8.2% | 5.6% | Near average | |
Quality | 38 | -75.6% | 7.6% | Near average | |
Safety | 52 | 0.6x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 55 | — | — | Near average | |
Sentiment | 29 | — | — | Below average |
Vanda Pharmaceuticals Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Vanda Pharmaceuticals Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Vanda stock has seen stability in its average price target at $14.25, with a slight improvement of 0.56% over the past 30 days. Notably, the number of analysts participating in coverage has increased from one analyst to 3 analysts recently, reflecting growing institutional interest despite the current market price ($5.99) remaining below the lowest analyst expectations ($7.5).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.